EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 28 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,015,966 | -27.7% | 1,693,559 | 0.0% | 0.03% | -24.4% |
| Q2 2023 | $1,405,993 | +135.4% | 1,693,559 | 0.0% | 0.04% | +125.0% |
| Q1 2023 | $597,318 | -17.5% | 1,693,559 | 0.0% | 0.02% | -35.5% |
| Q4 2022 | $724,166 | -25.3% | 1,693,559 | 0.0% | 0.03% | -31.1% |
| Q3 2022 | $969,000 | -59.7% | 1,693,559 | 0.0% | 0.04% | -59.1% |
| Q2 2022 | $2,405,000 | -12.4% | 1,693,559 | +150.0% | 0.11% | +0.9% |
| Q1 2022 | $2,744,000 | – | 677,452 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,822,114 | $67,027,000 | 15.21% |
| Column Group LLC | 4,309,329 | $60,546,000 | 6.89% |
| SECTORAL ASSET MANAGEMENT INC | 2,882,744 | $40,503,000 | 3.37% |
| Blackstone Inc. | 1,308,587 | $18,386,000 | 0.04% |
| Virtu Financial LLC | 17,444 | $245,000 | 0.02% |
| Verition Fund Management LLC | 24,667 | $347,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,859 | $97,000 | 0.00% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 430 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,005 | $337,000 | 0.00% |